Skip to main content
SpringerLink
Log in

Resistentie: gevecht tussen mens en micro-organisme

  • Chapter
  • First Online:
Antibiotica en infecties

Samenvatting

Van resistentie wordt gesproken als een micro-organisme niet meer gevoelig is voor een klinisch relevante concentratie van een antimicrobieel middel, of als bij de ziekteverwekker (bacterie, virus, schimmel) een mechanisme of eigenschap kan worden aangetoond waaruit blijkt dat dit middel niet effectief zal zijn. Multiresistentie is een scala aan resistenties bij één micro-organisme.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 44.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatuur

  1. Abraham-Inpijn L. Internet learning antibiotica E-wise. 2012

    Google Scholar 

  2. Fanoy E. Antibioticaresistentie in vogelvlucht. Infectieziekten Bulletin GGD Midden-Nederland, Centrum Infectiebestrijding, RIVM. Bilthoven. April 2012.

    Google Scholar 

  3. Soares GM, Figueiredo LC, Faveri M, Cortelli SC, Duarte PM, Feres M. Mechanisms of action of systemic antibiotics used in periodontal treatment and mechanisms of bacterial resistance to these drugs. J Appl Oral Sci. 2012;20(3):295–309.

    Article  PubMed Central  PubMed  Google Scholar 

  4. NETHMAP 2013 NETH 20 MARAN 2013 – Wageningen UR Monitoring of Antimicrobial Resistance and Antibiotic Usage in Animals in The Netherlands in 2012. juni 2013.

    Google Scholar 

  5. Nethmap Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. Jaarverslag 2013.

    Google Scholar 

  6. Garg A, Revankar AV. Spina bifida and dental care: key clinical issues. J Calif Dent Assoc. 2012;40(11):861–5.

    PubMed  Google Scholar 

  7. Editorial Ingest voor superbacteriën. Medisch Contact. 2010;65(33–34):1609.

    Google Scholar 

  8. European Antibiotic Awareness, 338. Antimicrobial resistance. Special Eurobarometer 10 april 2000.

    Google Scholar 

  9. Wise R, Hart T, Cars O, Streulens MJ, Helmuth R, Huovinen P, Sprenger M. Antimicrobial resistance. BMJ. 1998;317:609–10.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Denis O, Malaviolle X, Titeca G, Struelens MJ, Garrino MG, Glupczynnski Y, Etienne J. Emergence of Panton-Valentine leukocidin community-acquired MRSA infections in Belgium. Eurosurveillance Wkly. 2004;8(24).

    Google Scholar 

  11. Morgan M. Staphylococcus aureus, Panton-Valentine leukocidin, and necrotising pneumonia. BMJ. 2005;331:793–4.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Graaf A van de. Snellere test verkort onnodig isolement patiënten. Diagned. 2005:8–9.

    Google Scholar 

  13. Degener JE. De gevolgen van bacteriële resistentie tegen antibiotica. Geneesm bull. 1999;33(6):61–5.

    Google Scholar 

  14. Klevens RM, Gorwitz RJ, Collins AS. Methicilline-resistente staphylococcus aureus. A primer for dentists. J Am Dent Assoc. 2008;139:1328–37.

    Article  PubMed  Google Scholar 

  15. Ekert O, Gatermann S, Kuffner HD, Wagner W. Mögliche MRSA-infektketten in der MKG-Chirurgie. Dtsch Zahnärztl Z. 1997;52(11):749–51.

    Google Scholar 

  16. Nethmap. Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. Jaarverslag 2011.

    Google Scholar 

  17. Rijksinstituut voor Volksgezondheid. Surveillance van MRSA in Nederland in 2011. Bulletin September 2012.

    Google Scholar 

  18. Vandenbroucke-Grauls CMJE. Methicilline-resistentie Staphylococcus epidermidis. Ned Tijdschr Geneeskd. 1996;140(3):138–40.

    PubMed  Google Scholar 

  19. Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y. Clinical and economic impact of bacteremia with extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2006;50:1257–62.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Tumbarello M, Sanguinetti M, Montuori E, Trecarichi EM, Posteraro B, Fiori B, Citton R, D’Inzeo T, Fadda G, Cauda R, Spanu T. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother. 2007;51:1987–94. (Erratum in: Antimicrob Agents Chemother 2007; 51: 3469).

    Google Scholar 

  21. www.rivm.nl/cib/themas/isis-ar/

  22. Bonten MJM, Kluytmans J, Kulberg BJ. Carbapenemase-resistentie van gramnegatieve bacteriën. NTvG. 2010;154(37):1708–11.

    Google Scholar 

  23. Kluytmans J, Vandenbroucke-Grauls C, Meer JWM van der. Antibiotica-resistentie: maatregelen hoog nodig. NTvG. 2010;154(37):1711–5.

    Google Scholar 

  24. Leverstein-van Hall MA, Stuart JC, Voets GM, Versteeg D, Roelafsen A, Fluit AC. Carbapenem-resistentie Klebsiella pneumoniae na verblijf in het buitenland. NTvG. 2010;154(37):1736–41.

    Google Scholar 

  25. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev. 2005;18:657–86.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Kuster SP, Hasse B, Huebner V, Bansal V, Zbinden R, Ruef C, Ledergerber B, Weber R. Risks factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care university hospital in Switzerland. Infection. 2010;38(1):33–40.

    Article  PubMed  Google Scholar 

  27. Kuijper EJ, Dissel JT van. Opmars van resistente gramnegatieve bacteriën. NTvG. 2010;154(45):2005–99.

    Google Scholar 

  28. Stichting Werkgroep Infectie Preventie (WIP). www.wip.nl. 2014.

  29. Leverstein-van Hall MA. Veel gestelde vragen over BSL. Infectieziekte bulletin 06-januari 2012.

    Google Scholar 

  30. Rijksinstituut voor Volksgezondheid en Milieu. STEC/EHEC -http://www.rivm.nl/Onderwerpen/E/Escherichia_coli_E_coli/STEC_EHEC 2014.

  31. SWAB. NethMap. Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. www.swab.nl. 2012

  32. Prins J. A-team bindt strijd aan met resistentie. Medisch Contact. 2013;68(1):836–839.

    Google Scholar 

  33. Rogers SN, Proczek K, Sen RA, Hughes J, Banks P, Lowe D. Which patients are most at risk of methicillin resistant Staphylococcus aureus: a review of admissions to a regional maxillofacial ward between 2001 and 2005. Br J Oral Maxillofac Surg. 2008;46(6):439–44.

    Article  PubMed  Google Scholar 

  34. Tuzuner-Oncul AM, Ungor C, Dede U, Kisnisci RS. Methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis of the mandible. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107(6):e1–4

    Article  PubMed  Google Scholar 

  35. Zimmerli W, Sendi P. Antibiotics for prevention of periprosthetic joint infection following dentistry:time, focus on data. Clin Infect Dis. 2010;50:17–9.

    Article  Google Scholar 

  36. Rhodus N. Use of antibiotics in medically compromised patients in relation to oral health. International Congress of Disability and Oral health (IADH); 27 Augustus 2010.

    Google Scholar 

  37. Daha, T, Vandenbroucke-Grauls CMJE. Wat is het beleid/advies bij een MRSA-patiënt in de huisartspraktijk? Vademecum. 1999;17(11a):1–3.

    Google Scholar 

  38. Meis JFGM, Neeleman C. Resistentieproblemen bij Streptococcus pneumoniae. Ned Tijdschr Geneeskd. 1996;140(3):141–4.

    PubMed  Google Scholar 

  39. Bremenkamp RM, Caris AR, Jorge AO, Back-Brito GN, Mota AJ, Balducci I, Brighenti FL, Koga-Ito CY. Prevalence and antifungal resistance profile of Candida spp. oral isolates from patients with type 1 and 2 diabetes mellitus. Arch Oral Biol. 2011;56(6):549–55.

    Article  PubMed  Google Scholar 

  40. Cuesta AI, Jewtuchowicz VM, Brusca MI, Mujica MT, Rosa AC. Antibiotic susceptibility of Staphylococcus aureus isolates in oral mucosa and pockets of patients with gingivitis-periodontitis. Acta Odontol Latinoam. 2011;24(1):35–40.

    PubMed  Google Scholar 

  41. O’Leary E, Lockhart DE, Smith A. Coming to a practice near you? Community-acquired methicillin resistant Staphylococcus aureus (CA-MRSA). Dent Update. 2011;38(4):254–56.

    Google Scholar 

  42. Buonavoglia A, Latronico F, Greco MF, D’Abramo M, Marinaro M, Mangini F, Corrente M. Methicillin-resistant staphylococci carriage in the oral cavity: a study conducted in Bari (Italy). Oral Dis. 2010;16(5):465–8.

    Article  PubMed  Google Scholar 

  43. Smiline GA, Pandi SK, Hariprasad P, Raguraman R. A preliminary study on the screening of emerging drug resistance among the caries pathogens isolated from carious dentine. Indian J Dent Res. 2012;23(1):26–30.

    Article  PubMed  Google Scholar 

  44. Poeta P, Igrejas G, Gonçalves A, Martins E, Araújo C, Carvalho C, Rodrigues J, Vinué L, López M, Torres C. Influence of oral hygiene in patients with fixed appliances in the oral carriage of antimicrobial-resistant Escherichia coli and Enterococcus isolates. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108(4):557–64.

    Article  PubMed  Google Scholar 

  45. Roda RP, Bagan JV, Bielsa JMS, Pator EC. Antibiotic use in dental practice. A review. Med. Oral Patol Oral cir Bucal. 2007;12:E186–92.

    Google Scholar 

  46. Bidault P, Chandad F, Grenier D. Risk of Bacterial resistance associated with systemic antibiotic therapy in periodontology. JCDA. 2007;73(8):721–6.

    PubMed  Google Scholar 

  47. Ardila CM, López MA, Guzmán IC. High resistance against clindamycin, metronidazole and amoxicillin in Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans isolates of periodontal disease. Med Oral Patol Oral Cir Bucal. 2010;15(6):e947–51.

    Article  PubMed  Google Scholar 

  48. Horiba N, Yoshida T, Suzuki K, Maekawa Y, Ito M, Matsumoto T, Nakamura H. Isolation of methicillin-resistant staphylococci in the dental operatory. J Endod. 1995:21(1):21–5.

    Article  PubMed  Google Scholar 

  49. Ardila CM, Granada MI, Guzmán IC. Antibiotic resistance of subgingival species in chronic periodontitis patients. J Periodontal Res. 2010;45(4):557–63.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Amsterdam, Noord-Holland, The Netherlands

    L. Abraham-Inpijn

Authors
  1. L. Abraham-Inpijn
    View author publications

    You can also search for this author in PubMed Google Scholar

Copyright information

© 2016 Bohn Stafleu van Loghum

About this chapter

Cite this chapter

Abraham-Inpijn, L. (2016). Resistentie: gevecht tussen mens en micro-organisme. In: Antibiotica en infecties. Bohn Stafleu van Loghum, Houten. https://doi.org/10.1007/978-90-368-0542-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-90-368-0542-1_6

  • Published:

  • Publisher Name: Bohn Stafleu van Loghum, Houten

  • Print ISBN: 978-90-368-0541-4

  • Online ISBN: 978-90-368-0542-1

  • eBook Packages: Dutch language eBook collection

Publish with us

Policies and ethics

Search

Navigation